About MedReleaf (TSE:LEAF)
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Industry, Sector and Symbol
Trailing P/E Ratio1184.5
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity1.78%
Return on Assets1.43%
MedReleaf (TSE:LEAF) Frequently Asked Questions
What is MedReleaf's stock symbol?
MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."
Where is MedReleaf's stock going? Where will MedReleaf's stock price be in 2018?
2 brokers have issued 1-year target prices for MedReleaf's stock. Their forecasts range from C$20.00 to C$36.00. On average, they expect MedReleaf's stock price to reach C$25.33 in the next twelve months. View Analyst Ratings for MedReleaf.
Who are some of MedReleaf's key competitors?
Some companies that are related to MedReleaf include Jean Coutu Group PJC (PJC.A), Toromont Industries (TIH), Maxar Technologies (MAXR), Maple Leaf Foods (MFI), Ritchie Bros. Auctioneers (RBA), Canada Goose (GOOS), Yamana Gold (YRI), Kirkland Lake Gold (KL), Whitecap Resources (WCP), Stantec (STN), SmartCentres Real Estate Investment Trst (SRU.UN), Northland Power (NPI), B2Gold (BTO), Tmx Group (X), Domtar (UFS), Cogeco Communications (CCA), Allied Properties Real Estate Investment (AP.UN) and Genworth MI Canada (MIC).
Who are MedReleaf's key executives?
MedReleaf's management team includes the folowing people:
- Eitan Popper, President (Age 35)
- Neil Closner, Chief Executive Officer, Executive Director
- Igor Gimelshtein, Chief Financial Officer, Corporate Secretary
- Angelo Fefekos, Vice President - Clinical Affairs and Quality Compliance
- Darren Karasiuk, Vice President - Strategy
- Ivan Latysh, Vice President - Information Technology
- Lloyd M. Segal, Non-Executive Chairman of the Board (Age 51)
- Norma Beauchamp, Non-Executive Director
- Ronald Funk, Non-Executive Director
- Deborah E. Rosati, Non-Executive Director (Age 55)
How do I buy MedReleaf stock?
Shares of MedReleaf and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is MedReleaf's stock price today?
One share of MedReleaf stock can currently be purchased for approximately C$23.69.
How big of a company is MedReleaf?
MedReleaf has a market capitalization of C$2.24 billion.
MarketBeat Community Rating for MedReleaf (LEAF)MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for MedReleaf (TSE:LEAF)
No earnings announcements for this company have been tracked by MarketBeat.com
MedReleaf (TSE:LEAF) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for MedReleaf (TSE:LEAF)
No dividend announcements for this company have been tracked by MarketBeat.com
MedReleaf (TSE LEAF) Insider Trading and Institutional Ownership History
MedReleaf (TSE LEAF) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
MedReleaf (TSE LEAF) News Headlines
MedReleaf (TSE:LEAF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
MedReleaf (TSE LEAF) Stock Chart for Tuesday, January, 16, 2018